Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Lisata Therapeutics (LSTA) Other financing activities (2016 - 2017)

Lisata Therapeutics filings provide 4 years of Other financing activities readings, the most recent being $231.0 for Q4 2017.

For the quarter ending Q4 2017, Other financing activities fell 99.53% year-over-year to $231.0, compared with a TTM value of $231.0 through Sep 2018, up 100.93%, and an annual FY2017 reading of -$74000.0, down 101.85% over the prior year.
Other financing activities hit $231.0 in Q4 2017 for Lisata Therapeutics, down from $42314.0 in the prior quarter.
The five-year high for Other financing activities was $49446.0 in Q4 2016, with the low at -$138127.0 in Q3 2016.